Literature DB >> 27407393

Multicentric Castleman's Disease.

M K Gupta1, S K Magu2, A Behl3.   

Abstract

Entities:  

Keywords:  Angiofollicular hyperplasia; Lymph node

Year:  2011        PMID： 27407393      PMCID： PMC4925328          DOI： 10.1016/S0377-1237(02)80141-1

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  7 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

Review 2.  Castleman's disease and related disorders.

Authors:  G Frizzera
Journal:  Semin Diagn Pathol       Date:  1988-11       Impact factor: 3.464

3.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

4.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

5.  Retinoic acid for treatment of multicentric Castleman's disease.

Authors:  P Rieu; D Droz; A Gessain; J P Grünfeld; O Hermine
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

6.  Expression of interleukin-6 in Castleman's disease.

Authors:  S M Hsu; J A Waldron; S S Xie; B Barlogie
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

7.  Molecular analysis of clonality in Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; J M Micléa; P Cacoub; A Baruchel; P Brice; J P Clauvel; M F d'Agay; M Raphael
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.